SCHEMBL3131533

SCHEMBL3131533

CCN1C(=O)/C(=C/c2ccc(-c3ccccc3)o2)SC1=S

nearest known ligand 0.78

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.78
MAPT P10636 3/20 0.72
POLB P06746 2/20 0.72
ALDH1A1 P00352 2/20 0.72
LMNA P02545 2/20 0.72
RAB9A P51151 1/20 0.72
TNFRSF1A P19438 2/20 0.69
EP300 Q09472 1/20 0.64
CREBBP Q92793 1/20 0.64
APEX1 P27695 1/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
ITGB2 P05107 1/20 0.60
ITGAM P11215 1/20 0.60
HIF1AN Q9NWT6 1/20 0.60
MAP3K5 Q99683 4/20 0.59
ALOX12 P18054 1/20 0.58
RECQL P46063 1/20 0.58
MCL1 Q07820 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3131544 1.00 STAT3 (0.78) STAT3MAPTPOLBALDH1A1LMNA
SCHEMBL3131549 1.00 STAT3 (0.78) STAT3MAPTPOLBALDH1A1LMNA
SCHEMBL3125516 0.92 MAPT (0.74) STAT3MAPTPOLBALDH1A1LMNA
SCHEMBL3125529 0.92 MAPT (0.74) STAT3MAPTPOLBALDH1A1LMNA
SCHEMBL3125527 0.92 MAPT (0.74) STAT3MAPTPOLBALDH1A1LMNA
SCHEMBL12812670 0.88 STAT3 (0.78) STAT3MAPTPOLBALDH1A1LMNA
SCHEMBL17088410 0.88 ITGB2 (0.71) STAT3MAPTPOLBALDH1A1LMNA
SCHEMBL1430728 0.88 STAT3 (1.00) STAT3TNFRSF1AAPEX1MEN1KMT2A
SCHEMBL16496688 0.88 STAT3 (1.00) STAT3TNFRSF1AAPEX1MEN1KMT2A
SCHEMBL3132328 0.87 MAPT (0.73) STAT3MAPTPOLBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US claimed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO claimed
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US disclosed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses MAVS, LAMP1, HAVCR2 STAT3 4654/4885MAPT 3126/4885POLB 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.